Cardiovascular
Cardiovascular Disease
Highlights from 2013 ICAAC, IDWeek, and EACS Meetings
- Details
- Category: HIV Treatment
- Published on Tuesday, 28 January 2014 00:00
- Written by HIVandHepatitis.com
Latest Positive Pulse Newsletter
In this overview Paul Sax from Harvard Medical School and Mark Sulkowski from Johns Hopkins discuss selected highlights from this fall's Interscience Conference on Microbial Agents and Chemotherapy (ICAAC), IDWeek, and the European AIDS Conference. The newsletter is available to all for free, with continuing medical education (CME) credit available for physicians and nurses.
Low CD4 Count Raises Risk of Heart Attack, Bone Loss
- Details
- Category: Cardiovascular Disease
- Published on Thursday, 23 January 2014 00:00
- Written by Liz Highleyman
HIV positive people whose CD4 T-cell count falls below 200 cells/mm3 are at greater risk for myocardial infarction, though the heart attack rate is not elevated for people with counts of 500 cells/mm3 or more, researchers recently reported. Another study found that people with low CD4 counts have a higher likelihood of bone loss after starting antiretroviral therapy (ART).
HIV Medicine Association Guidelines Emphasize Primary Care Needs of People with HIV on ART
- Details
- Category: HIV Treatment
- Published on Thursday, 14 November 2013 00:00
- Written by Liz Highleyman
The HIV Medicine Association (HIVMA) of the Infectious Disease Society of America (IDSA) this week released new Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus, focusing on primary care and prevention for HIV positive people on effective antiretroviral therapy (ART). The new guidelines, published in the November 13, 2013, online edition of Clinical Infectious Diseases (in print January 2014) "reflect the fact that people with HIV are now living normal life spans," according to an HIVMA/IDSA press release.
HIV Infection Linked to Structural Heart Disease
- Details
- Category: Cardiovascular Disease
- Published on Monday, 23 December 2013 00:00
- Written by European Society of Cardiology
People with HIV who have detectable viral load are more likely to have structural heart problems such as left ventricular hypertrophy, diastolic dysfunction, or pulmonary hypertension, according to research presented at the recent EuroEcho-Imaging 2013 conference in Istanbul.
IDWeek 2013: Complera Works Well Regardless of Viral Load or CD4 Count, Improves Lipid Levels
- Details
- Category: HIV Treatment
- Published on Friday, 11 October 2013 00:00
- Written by Liz Highleyman
The single-tablet regimen Complera (rilpivirine/tenofovir/emtricitabine) worked as well as Atripla (efavirenz/tenofovir/emtricitabine) for treatment-naive people across a range of viral load and CD4 T-cell levels, researchers reported at the Second IDWeek conference last week in San Francisco. Another study found that switching from a boosted protease inhibitor to Complera lowered cholesterol and triglyceride levels.
Web Design and Development by